{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:57:09Z","timestamp":1790632629342,"version":"4.1.0"},"reference-count":144,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.peptides.2012.04.008","type":"journal-article","created":{"date-parts":[[2012,4,17]],"date-time":"2012-04-17T19:15:38Z","timestamp":1334690138000},"page":"142-150","source":"Crossref","is-referenced-by-count":84,"title":["The retinal renin\u2013angiotensin system: Roles of angiotensin II and aldosterone"],"prefix":"10.1016","volume":"36","author":[{"given":"Jennifer L.","family":"Wilkinson-Berka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Agrotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devy","family":"Deliyanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2012.04.008_bib0005","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1056\/NEJM200002103420603","article-title":"Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy","volume":"342","author":"The Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications Research Group","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.peptides.2012.04.008_bib0010","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","article-title":"Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38","volume":"317","author":"United Kingdom Prospective Diabetes Study Group","year":"1998","journal-title":"Br Med J"},{"key":"10.1016\/j.peptides.2012.04.008_bib0015","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0002-9440(10)63001-5","article-title":"Inhibition of NAD(P)H oxidase activity blocks vascular endothelial growth factor overexpression and neovascularization during ischemic retinopathy","volume":"167","author":"Al-Shabrawey","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1016\/j.peptides.2012.04.008_bib0020","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1167\/iovs.08-1755","article-title":"Role of NADPH oxidase in retinal vascular inflammation","volume":"49","author":"Al-Shabrawey","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.peptides.2012.04.008_bib0025","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.exer.2009.06.014","article-title":"(Pro)renin receptor is expressed in human retinal pigment epithelium and participates in extracellular matrix remodeling","volume":"89","author":"Alcazar","year":"2009","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.peptides.2012.04.008_bib0030","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1136\/bjo.38.7.397","article-title":"Effect of oxygen on developing retinal vessels with particular reference to the problem of retrolental fibroplasia","volume":"38","author":"Ashton","year":"1954","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.peptides.2012.04.008_bib0035","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1172\/JCI2425","article-title":"Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin","volume":"102","author":"Barber","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.peptides.2012.04.008_bib0040","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1152\/physrev.00044.2005","article-title":"The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology","volume":"87","author":"Bedard","year":"2007","journal-title":"Physiol Rev"},{"key":"10.1016\/j.peptides.2012.04.008_bib0045","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/emmm.201000080","article-title":"Angiotensin II revisited: new roles in inflammation, immunology and aging","volume":"2","author":"Benigni","year":"2010","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.peptides.2012.04.008_bib0050","first-page":"1450","article-title":"Renin-containing Muller cells of the retina display endocrine features","volume":"36","author":"Berka","year":"1995","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.peptides.2012.04.008_bib0055","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/ncpneph0575","article-title":"The incidence and implications of aldosterone breakthrough","volume":"3","author":"Bomback","year":"2007","journal-title":"Nat Clin Pract Nephrol"},{"key":"10.1016\/j.peptides.2012.04.008_bib0060","doi-asserted-by":"crossref","first-page":"755","DOI":"10.3109\/02713689409047011","article-title":"Renin mRNA is synthesized locally in rat ocular tissues","volume":"13","author":"Brandt","year":"1994","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.peptides.2012.04.008_bib0065","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/archopht.1984.01040031057023","article-title":"Electroretinographic oscillatory potentials predict progression of diabetic retinopathy. Preliminary report","volume":"102","author":"Bresnick","year":"1984","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.peptides.2012.04.008_bib0070","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1001\/archopht.1987.01060060096041","article-title":"Predicting progression to severe proliferative diabetic retinopathy","volume":"105","author":"Bresnick","year":"1987","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.peptides.2012.04.008_bib0075","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s00417-009-1082-x","article-title":"Involvement of Muller glial cells in epiretinal membrane formation","volume":"247","author":"Bringmann","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.peptides.2012.04.008_bib0080","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00125-003-1042-7","article-title":"ACE inhibition salvages the visual loss caused by diabetes","volume":"46","author":"Bui","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.peptides.2012.04.008_bib0085","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.cellsig.2012.02.005","article-title":"Angiotensin II modulates VEGF-driven angiogenesis by opposing effects of type 1 and type 2 receptor stimulation in the microvascular endothelium","volume":"24","author":"Carbajo-Lozoya","year":"2012","journal-title":"Cell Signal"},{"key":"10.1016\/j.peptides.2012.04.008_bib0090","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0140-6736(97)06209-0","article-title":"Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus","volume":"351","author":"Chaturvedi","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.peptides.2012.04.008_bib0095","doi-asserted-by":"crossref","first-page":"R1619","DOI":"10.1152\/ajpregu.00290.2007","article-title":"Role of NADPH oxidase and ANG II in diabetes-induced retinal leukostasis","volume":"293","author":"Chen","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.peptides.2012.04.008_bib0100","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.exer.2006.05.009","article-title":"Role of angiotensin II in retinal leukostasis in the diabetic rat","volume":"83","author":"Chen","year":"2006","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.peptides.2012.04.008_bib0105","first-page":"1008","article-title":"Angiotensin levels in the eye","volume":"35","author":"Danser","year":"1994","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.peptides.2012.04.008_bib0110","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1210\/jcem-68-1-160","article-title":"Renin, prorenin, and immunoreactive renin in vitreous fluid from eyes with and without diabetic retinopathy","volume":"68","author":"Danser","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.peptides.2012.04.008_bib0115","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1210\/endo-126-3-1673","article-title":"Identification and quantification of renin and prorenin in the bovine eye","volume":"126","author":"Deinum","year":"1990","journal-title":"Endocrinology"},{"key":"10.1016\/j.peptides.2012.04.008_bib0120","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1161\/HYPERTENSIONAHA.111.188136","article-title":"Neovascularization is attenuated with aldosterone synthase inhibition in rats with retinopathy","volume":"59","author":"Deliyanti","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.peptides.2012.04.008_bib0125","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1100\/tsw.2009.70","article-title":"Angiotensin-(1\u20137) and its effects in the kidney","volume":"9","author":"Dilauro","year":"2009","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.peptides.2012.04.008_bib0130","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/cne.22205","article-title":"Angiotensin type-1 receptor inhibition is neuroprotective to amacrine cells in a rat model of retinopathy of prematurity","volume":"518","author":"Downie","year":"2010","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.peptides.2012.04.008_bib0135","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/glia.20680","article-title":"AT1 receptor inhibition prevents astrocyte degeneration and restores vascular growth in oxygen-induced retinopathy","volume":"56","author":"Downie","year":"2008","journal-title":"Glia"},{"key":"10.1016\/j.peptides.2012.04.008_bib0140","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.neuroscience.2009.02.084","article-title":"Neuronal and glial cell expression of angiotensin II type 1 (AT1) and type 2 (AT2) receptors in the rat retina","volume":"161","author":"Downie","year":"2009","journal-title":"Neuroscience"},{"issue":"Suppl 2","key":"10.1016\/j.peptides.2012.04.008_bib0145","first-page":"B54","article-title":"Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes","volume":"23","author":"Estacio","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.peptides.2012.04.008_bib0150","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1161\/HYPERTENSIONAHA.107.108845","article-title":"Effects of aliskiren on blood pressure, albuminuria, and (pro)renin receptor expression in diabetic TG(mRen-2)27 rats","volume":"52","author":"Feldman","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.peptides.2012.04.008_bib0155","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.preteyeres.2010.03.003","article-title":"The renin\u2013angiotensin system in retinal health and disease: its influence on neurons, glia and the vasculature","volume":"29","author":"Fletcher","year":"2010","journal-title":"Prog Retin Eye Res"},{"issue":"Suppl 1","key":"10.1016\/j.peptides.2012.04.008_bib0160","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.2337\/diacare.27.2007.S84","article-title":"Retinopathy in diabetes","volume":"27","author":"Fong","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.peptides.2012.04.008_bib0165","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1080\/02713680802389851","article-title":"Involvement of angiotensin II-dependent vascular endothelial growth factor gene expression via NADPH oxidase in the retina in a type 2 diabetic rat model","volume":"33","author":"Fukumoto","year":"2008","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.peptides.2012.04.008_bib0170","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.mce.2008.11.003","article-title":"NADPH oxidases and angiotensin II receptor signaling","volume":"302","author":"Garrido","year":"2009","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.peptides.2012.04.008_bib0175","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1167\/iovs.05-1376","article-title":"Loss of cholinergic and dopaminergic amacrine cells in streptozotocin-diabetic rat and Ins2Akita-diabetic mouse retinas","volume":"47","author":"Gastinger","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.peptides.2012.04.008_bib0180","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1089\/108076803322660503","article-title":"Angiotensin converting enzyme (ACE) activity in porcine ocular tissue: effects of diet and ACE inhibitors","volume":"19","author":"Geng","year":"2003","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.peptides.2012.04.008_bib0185","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","article-title":"Oxidative stress and diabetic complications","volume":"107","author":"Giacco","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.peptides.2012.04.008_bib0190","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/MED.0b013e3283391989","article-title":"Aldosterone and inflammation","volume":"17","author":"Gilbert","year":"2010","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.peptides.2012.04.008_bib0195","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1007\/s001250051539","article-title":"Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes","volume":"43","author":"Gilbert","year":"2000","journal-title":"Diabetologia"},{"key":"10.1016\/j.peptides.2012.04.008_bib0200","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/1098-1136(200102)33:2<160::AID-GLIA1015>3.0.CO;2-4","article-title":"Epithelial sodium channel and the mineralocorticoid receptor in cultured rat Muller glial cells","volume":"33","author":"Golestaneh","year":"2001","journal-title":"Glia"},{"key":"10.1016\/j.peptides.2012.04.008_bib0205","first-page":"221","article-title":"The mineralocorticoid receptor in rodent retina: ontogeny and molecular identity","volume":"8","author":"Golestaneh","year":"2002","journal-title":"Mol Vis"},{"key":"10.1016\/j.peptides.2012.04.008_bib0210","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1136\/bjo.2005.081166","article-title":"Retinopathy of prematurity","volume":"90","author":"Good","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.peptides.2012.04.008_bib0215","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1172\/JCI115395","article-title":"Expression of AT2 receptors in the developing rat fetus","volume":"88","author":"Grady","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.peptides.2012.04.008_bib0220","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.2337\/dc11-0476","article-title":"Benefits of renin\u2013angiotensin blockade on retinopathy in type 1 diabetes vary with glycemic control","volume":"34","author":"Harindhanavudhi","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.peptides.2012.04.008_bib0225","first-page":"96","article-title":"Studies on the pathogenesis of avascular retina and neovascularization into the vitreous in peripheral severe retinopathy of prematurity (an American Ophthalmological Society Thesis)","volume":"108","author":"Hartnett","year":"2010","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.peptides.2012.04.008_bib0230","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1076\/ceyr.27.2.123.15955","article-title":"Captopril and vascular endothelial growth factor in a mouse model of retinopathy","volume":"27","author":"Higgins","year":"2003","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.peptides.2012.04.008_bib0235","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1755-3768.1981.tb08744.x","article-title":"Contrast sensitivity function in evaluation of visual impairment due to retinitis pigmentosa","volume":"59","author":"Hyvarinen","year":"1981","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"10.1016\/j.peptides.2012.04.008_bib0240","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ajo.2005.08.066","article-title":"Correlation between angiotensin-converting enzyme, vascular endothelial growth factor, and matrix metalloproteinase-9 in the vitreous of eyes with diabetic retinopathy","volume":"141","author":"Ishizaki","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.peptides.2012.04.008_bib0245","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1113\/jphysiol.2004.073098","article-title":"Effects of angiotensin II on the pericyte-containing microvasculature of the rat retina","volume":"561","author":"Kawamura","year":"2004","journal-title":"J Physiol"},{"key":"10.1016\/j.peptides.2012.04.008_bib0250","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.1113\/jphysiol.2008.156695","article-title":"Retinal ganglion cells in diabetes","volume":"586","author":"Kern","year":"2008","journal-title":"J Physiol"},{"key":"10.1016\/j.peptides.2012.04.008_bib0255","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1017\/S0952523800008762","article-title":"Angiotensin II in the rabbit retina","volume":"14","author":"Kohler","year":"1997","journal-title":"Vis Neurosci"},{"key":"10.1016\/j.peptides.2012.04.008_bib0260","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.2337\/diabetes.54.5.1559","article-title":"Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy","volume":"54","author":"Krady","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.peptides.2012.04.008_bib0265","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.2337\/db07-1281","article-title":"Angiotensin II type 1 receptor signaling contributes to synaptophysin degradation and neuronal dysfunction in the diabetic retina","volume":"57","author":"Kurihara","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.peptides.2012.04.008_bib0270","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/1470320309347785","article-title":"The angiotensin II type 2 receptor in cardiovascular disease","volume":"11","author":"Lemarie","year":"2010","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.peptides.2012.04.008_bib0275","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1161\/CIRCRESAHA.109.196576","article-title":"Aldosterone-induced activation of signaling pathways requires activity of angiotensin type 1a receptors","volume":"105","author":"Lemarie","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.peptides.2012.04.008_bib0280","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.2337\/db09-1057","article-title":"Inhibition of reactive oxygen species by Lovastatin downregulates vascular endothelial growth factor expression and ameliorates blood-retinal barrier breakdown in db\/db mice: role of NADPH oxidase 4","volume":"59","author":"Li","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.peptides.2012.04.008_bib0285","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2337\/diabetes.47.5.815","article-title":"Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Penn State Retina Research Group","volume":"47","author":"Lieth","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.peptides.2012.04.008_bib0290","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1167\/iovs.06-0016","article-title":"The retinal vasculature and function of the neural retina in a rat model of retinopathy of prematurity","volume":"47","author":"Liu","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.peptides.2012.04.008_bib0295","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.exer.2011.12.012","article-title":"Activation of the aldosterone\/mineralocorticoid receptor system and protective effects of mineralocorticoid receptor antagonism in retinal ischemia-reperfusion injury","volume":"96","author":"Liu","year":"2012","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.peptides.2012.04.008_bib0300","first-page":"429","article-title":"Hyperoxia\/normoxia-driven retinal angiogenesis in mice: a role for angiotensin II","volume":"42","author":"Lonchampt","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.peptides.2012.04.008_bib0305","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1089\/jop.2008.0081","article-title":"Activities of angiotensin-converting enzymes ACE1 and ACE2 and inhibition by bioactive peptides in porcine ocular tissues","volume":"25","author":"Luhtala","year":"2009","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.peptides.2012.04.008_bib0310","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3109\/02713688909000874","article-title":"Angiotensin II receptors labelled with 125I-[Sar1, Ile8]-AII in albino rabbit ocular tissues","volume":"8","author":"Mallorga","year":"1989","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.peptides.2012.04.008_bib0315","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.earlhumdev.2011.05.009","article-title":"Mediators involved in retinopathy of prematurity and emerging therapeutic targets","volume":"87","author":"Mataftsi","year":"2011","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.peptides.2012.04.008_bib0320","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1056\/NEJMoa0808400","article-title":"Renal and retinal effects of enalapril and losartan in type 1 diabetes","volume":"361","author":"Mauer","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.peptides.2012.04.008_bib0325","doi-asserted-by":"crossref","first-page":"F396","DOI":"10.1152\/ajprenal.00576.2009","article-title":"Regulation of the renin expression in the retinal pigment epithelium by systemic stimuli","volume":"299","author":"Milenkovic","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.peptides.2012.04.008_bib0330","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.2337\/db10-0552","article-title":"Candesartan attenuates diabetic retinal vascular pathology by restoring glyoxalase-I function","volume":"59","author":"Miller","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.peptides.2012.04.008_bib0335","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1161\/01.HYP.36.6.1099","article-title":"Retinal neovascularization is prevented by blockade of the renin\u2013angiotensin system","volume":"36","author":"Moravski","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.peptides.2012.04.008_bib0340","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0002-9440(10)63806-0","article-title":"The renin\u2013angiotensin system influences ocular endothelial cell proliferation in diabetes: transgenic and interventional studies","volume":"162","author":"Moravski","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.peptides.2012.04.008_bib0345","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1136\/bjo.86.10.1172","article-title":"Inhibitory effect of losartan, an AT1 angiotensin II receptor antagonist, on increased leucocyte entrapment in retinal microcirculation of diabetic rats","volume":"86","author":"Mori","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.peptides.2012.04.008_bib0350","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1006\/bbrc.1999.1834","article-title":"Angiotensin II and retinal pericytes migration","volume":"266","author":"Nadal","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.peptides.2012.04.008_bib0355","doi-asserted-by":"crossref","first-page":"H739","DOI":"10.1152\/ajpheart.00656.2001","article-title":"Angiotensin II stimulates migration of retinal microvascular pericytes: involvement of TGF-beta and PDGF-BB","volume":"282","author":"Nadal","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.peptides.2012.04.008_bib0360","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1167\/iovs.04-1101","article-title":"Selective suppression of pathologic, but not physiologic, retinal neovascularization by blocking the angiotensin II type 1 receptor","volume":"46","author":"Nagai","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.peptides.2012.04.008_bib0365","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1161\/01.ATV.0000240050.15321.fe","article-title":"Angiotensin II type 1 receptor-mediated inflammation is required for choroidal neovascularization","volume":"26","author":"Nagai","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.peptides.2012.04.008_bib0370","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ejphar.2005.02.047","article-title":"Pharmacological and pharmacokinetic study of olmesartan medoxomil in animal diabetic retinopathy models","volume":"512","author":"Nakamura","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.peptides.2012.04.008_bib0375","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000217725","article-title":"Role of angiotensin II type 1 receptor on retinal vascular leakage in a rat oxygen-induced retinopathy model","volume":"41","author":"Nakamura","year":"2009","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.peptides.2012.04.008_bib0380","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1172\/JCI0214276","article-title":"Pivotal role of the renin\/prorenin receptor in angiotensin II production and cellular responses to renin","volume":"109","author":"Nguyen","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.peptides.2012.04.008_bib0385","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1161\/HYPERTENSIONAHA.108.110932","article-title":"Renin inhibition by aliskiren prevents atherosclerosis progression: comparison with irbesartan, atenolol, and amlodipine","volume":"51","author":"Nussberger","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.peptides.2012.04.008_bib0390","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0021-5155(01)00412-9","article-title":"Increased expression of angiotensin-converting enzyme in retinas of diabetic rats","volume":"45","author":"Okada","year":"2001","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.peptides.2012.04.008_bib0395","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2337\/diabetes.50.4.867","article-title":"Angiotensin II induces expression of the Tie2 receptor ligand, angiopoietin-2, in bovine retinal endothelial cells","volume":"50","author":"Otani","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.peptides.2012.04.008_bib0400","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1161\/01.RES.82.5.619","article-title":"Angiotensin II potentiates vascular endothelial growth factor-induced angiogenic activity in retinal microcapillary endothelial cells","volume":"82","author":"Otani","year":"1998","journal-title":"Circ Res"},{"key":"10.1016\/j.peptides.2012.04.008_bib0405","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1007\/s00125-003-1177-6","article-title":"Apoptotic death of photoreceptors in the streptozotocin-induced diabetic rat retina","volume":"46","author":"Park","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.peptides.2012.04.008_bib0410","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0140-6736(07)61303-8","article-title":"Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial","volume":"370","author":"Patel","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.peptides.2012.04.008_bib0415","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.1167\/iovs.04-0842","article-title":"Paired-flash identification of rod and cone dysfunction in the diabetic rat","volume":"45","author":"Phipps","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.peptides.2012.04.008_bib0420","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1167\/iovs.06-0892","article-title":"Retinal dysfunction in diabetic Ren-2 rats is ameliorated by treatment with valsartan but not atenolol","volume":"48","author":"Phipps","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.peptides.2012.04.008_bib0425","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1073\/pnas.92.3.905","article-title":"Vascular endothelial growth factor\/vascular permeability factor expression in a mouse model of retinal neovascularization","volume":"92","author":"Pierce","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.peptides.2012.04.008_bib0430","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.exer.2009.02.020","article-title":"Angiotensin II-induced hypertension regulates AT1 receptor subtypes and extracellular matrix turnover in mouse retinal pigment epithelium","volume":"89","author":"Praddaude","year":"2009","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.peptides.2012.04.008_bib0435","first-page":"834","article-title":"Cross-talk between aldosterone and angiotensin signaling in vascular smooth muscle cells","volume":"76","author":"Rautureau","year":"2011","journal-title":"Steroids"},{"key":"10.1016\/j.peptides.2012.04.008_bib0440","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1358\/dnp.2010.23.2.1475901","article-title":"The angiotensin AT2 receptor in inflammation","volume":"23","author":"Rompe","year":"2010","journal-title":"Drug News Perspect"},{"key":"10.1016\/j.peptides.2012.04.008_bib0445","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/ki.1994.453","article-title":"Renin processing and secretion in adrenal and retina of transgenic (mREN-2)27 rats","volume":"46","author":"Rong","year":"1994","journal-title":"Kidney Int"},{"key":"10.1016\/j.peptides.2012.04.008_bib0450","first-page":"1971","article-title":"Glial reactivity, an early feature of diabetic retinopathy","volume":"41","author":"Rungger-Brandle","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.peptides.2012.04.008_bib0455","first-page":"840","article-title":"Inhibition of NAD(P)H oxidase reduces apoptosis and avascular retina in an animal model of retinopathy of prematurity","volume":"13","author":"Saito","year":"2007","journal-title":"Mol Vis"},{"key":"10.1016\/j.peptides.2012.04.008_bib0460","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0002-9440(10)63448-7","article-title":"Retinal angiogenesis is mediated by an interaction between the angiotensin type 2 receptor, VEGF, and angiopoietin","volume":"163","author":"Sarlos","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.peptides.2012.04.008_bib0465","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1167\/iovs.04-0885","article-title":"The renin\u2013angiotensin system and the developing retinal vasculature","volume":"46","author":"Sarlos","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.peptides.2012.04.008_bib0470","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1167\/iovs.06-0534","article-title":"Role of nonproteolytically activated prorenin in pathologic, but not physiologic, retinal neovascularization","volume":"48","author":"Satofuka","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.peptides.2012.04.008_bib0475","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.2353\/ajpath.2008.080457","article-title":"(Pro)renin receptor promotes choroidal neovascularization by activating its signal transduction and tissue renin\u2013angiotensin system","volume":"173","author":"Satofuka","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.peptides.2012.04.008_bib0480","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.2337\/db08-0254","article-title":"(Pro)renin receptor-mediated signal transduction and tissue renin\u2013angiotensin system contribute to diabetes-induced retinal inflammation","volume":"58","author":"Satofuka","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.peptides.2012.04.008_bib0485","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1159\/000081633","article-title":"Immunohistochemical localization of angiotensin-converting enzyme, angiotensin II and AT1 receptor in human ocular tissues","volume":"36","author":"Savaskan","year":"2004","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.peptides.2012.04.008_bib0490","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1017\/S1462399411001815","article-title":"Angiotensin II and the vascular phenotype in hypertension","volume":"13","author":"Savoia","year":"2011","journal-title":"Expert Rev Mol Med"},{"key":"10.1016\/j.peptides.2012.04.008_bib0495","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1097\/HJH.0b013e3283060f2e","article-title":"Prorenin engages the (pro)renin receptor like renin and both ligand activities are unopposed by aliskiren","volume":"26","author":"Schefe","year":"2008","journal-title":"J Hypertens"},{"key":"10.1016\/j.peptides.2012.04.008_bib0500","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00109-008-0320-8","article-title":"PLZF and the (pro)renin receptor","volume":"86","author":"Schefe","year":"2008","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.peptides.2012.04.008_bib0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2012.02.012","article-title":"Targeting NADPH oxidases in vascular pharmacology","author":"Schramm","year":"2012","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.peptides.2012.04.008_bib0510","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1167\/iovs.06-1024","article-title":"Angiotensin II and its receptor subtypes in the human retina","volume":"48","author":"Senanayake","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.peptides.2012.04.008_bib0515","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.exer.2007.03.008","article-title":"Prevention of hypertension abrogates early inflammatory events in the retina of diabetic hypertensive rats","volume":"85","author":"Silva","year":"2007","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.peptides.2012.04.008_bib0520","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1464-5491.2010.03210.x","article-title":"Retinal microaneurysm count predicts progression and regression of diabetic retinopathy. Post hoc results from the DIRECT Programme","volume":"28","author":"Sjolie","year":"2011","journal-title":"Diabet Med"},{"key":"10.1016\/j.peptides.2012.04.008_bib0525","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0140-6736(08)61411-7","article-title":"Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial","volume":"372","author":"Sjolie","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.peptides.2012.04.008_bib0530","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/archopht.1985.01050010055018","article-title":"Contrast sensitivity in diabetics with and without background retinopathy","volume":"103","author":"Sokol","year":"1985","journal-title":"Arch Ophthalmol"},{"issue":"Suppl 1","key":"10.1016\/j.peptides.2012.04.008_bib0535","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1038\/jp.2008.47","article-title":"Clinical practices in neonatal oxygenation: where have we failed? What can we do?","volume":"28","author":"Sola","year":"2008","journal-title":"J Perinatol"},{"key":"10.1016\/j.peptides.2012.04.008_bib0540","first-page":"1749","article-title":"Ocular renin\u2013angiotensin: immunohistochemical evidence for the presence of prorenin in eye tissue","volume":"29","author":"Sramek","year":"1988","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.peptides.2012.04.008_bib0545","first-page":"1627","article-title":"An ocular renin\u2013angiotensin system. Immunohistochemistry of angiotensinogen","volume":"33","author":"Sramek","year":"1992","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.peptides.2012.04.008_bib0550","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/MNH.0b013e3283414d40","article-title":"New insights into angiotensin receptor actions: from blood pressure to aging","volume":"20","author":"Stegbauer","year":"2011","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.peptides.2012.04.008_bib0555","first-page":"290","article-title":"Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity","volume":"37","author":"Stone","year":"1996","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.peptides.2012.04.008_bib0560","doi-asserted-by":"crossref","first-page":"4738","DOI":"10.1523\/JNEUROSCI.15-07-04738.1995","article-title":"Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia","volume":"15","author":"Stone","year":"1995","journal-title":"J Neurosci"},{"key":"10.1016\/j.peptides.2012.04.008_bib0565","doi-asserted-by":"crossref","first-page":"C1633","DOI":"10.1152\/ajpcell.00092.2008","article-title":"Regulation of angiotensin II receptors and extracellular matrix turnover in human retinal pigment epithelium: role of angiotensin II","volume":"295","author":"Striker","year":"2008","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.peptides.2012.04.008_bib0570","first-page":"2209","article-title":"Localization of angiotensin converting enzyme in the ciliary epithelium of the rat eye","volume":"30","author":"Strittmatter","year":"1989","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.peptides.2012.04.008_bib0575","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.exer.2007.06.008","article-title":"Angiotensin II receptor blocker inhibits abnormal accumulation of advanced glycation end products and retinal damage in a rat model of type 2 diabetes","volume":"85","author":"Sugiyama","year":"2007","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.peptides.2012.04.008_bib0580","first-page":"1867","article-title":"Captopril improves retinal neovascularization via endothelin-1","volume":"42","author":"Tadesse","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.peptides.2012.04.008_bib0585","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.1751-7176.2011.00518.x","article-title":"Angiotensin receptor blockers: pharmacology, efficacy, and safety","volume":"13","author":"Taylor","year":"2011","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.peptides.2012.04.008_bib0590","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/MNH.0b013e328341164a","article-title":"Angiotensin-converting enzyme 2 is a key modulator of the renin\u2013angiotensin system in cardiovascular and renal disease","volume":"20","author":"Tikellis","year":"2011","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.peptides.2012.04.008_bib0595","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/02713680490517944","article-title":"Identification of angiotensin converting enzyme 2 in the rodent retina","volume":"29","author":"Tikellis","year":"2004","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.peptides.2012.04.008_bib0600","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1093\/eurheartj\/ehr253","article-title":"Therapeutic perspectives in hypertension: novel means for renin\u2013angiotensin\u2013aldosterone system modulation and emerging device-based approaches","volume":"32","author":"Unger","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.peptides.2012.04.008_bib0605","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/mt.2011.155","article-title":"ACE2 and Ang-(1\u20137) confer protection against development of diabetic retinopathy","volume":"20","author":"Verma","year":"2012","journal-title":"Mol Ther"},{"key":"10.1016\/j.peptides.2012.04.008_bib0610","doi-asserted-by":"crossref","first-page":"594","DOI":"10.2174\/157016111796642689","article-title":"Aldosterone, from (patho)physiology to treatment in cardiovascular and renal damage","volume":"9","author":"Waanders","year":"2011","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.peptides.2012.04.008_bib0615","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/bjo.80.2.159","article-title":"Demonstration of renin mRNA, angiotensinogen mRNA, and angiotensin converting enzyme mRNA expression in the human eye: evidence for an intraocular renin\u2013angiotensin system","volume":"80","author":"Wagner","year":"1996","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.peptides.2012.04.008_bib0620","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1006\/mvre.1999.2178","article-title":"Suppression of sodium-dependent glucose uptake by captopril improves high-glucose-induced morphological and functional changes of cultured bovine retinal pericytes","volume":"58","author":"Wakisaka","year":"1999","journal-title":"Microvasc Res"},{"key":"10.1016\/j.peptides.2012.04.008_bib0625","doi-asserted-by":"crossref","first-page":"945","DOI":"10.3109\/02713689309020401","article-title":"Ocular renin angiotensin: EM immunocytochemical localization of prorenin","volume":"12","author":"Wallow","year":"1993","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.peptides.2012.04.008_bib0630","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.2337\/db09-1420","article-title":"Muller cell-derived VEGF is essential for diabetes-induced retinal inflammation and vascular leakage","volume":"59","author":"Wang","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.peptides.2012.04.008_bib0635","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1161\/HYPERTENSIONAHA.108.116350","article-title":"Renin inhibition improves cardiac function and remodeling after myocardial infarction independent of blood pressure","volume":"52","author":"Westermann","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.peptides.2012.04.008_bib0640","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1046\/j.1460-9568.1999.00787.x","article-title":"Angiotensin II receptor subtype gene expression and cellular localization in the retina and non-neuronal ocular tissues of the rat","volume":"11","author":"Wheeler-Schilling","year":"1999","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.peptides.2012.04.008_bib0645","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1006\/exer.2000.0944","article-title":"Expression of angiotensin-converting enzyme (ACE) in the developing chicken retina","volume":"72","author":"Wheeler-Schilling","year":"2001","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.peptides.2012.04.008_bib0650","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0161-6420(03)00475-5","article-title":"Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales","volume":"110","author":"Wilkinson","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.peptides.2012.04.008_bib0655","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1161\/HYPERTENSIONAHA.109.148221","article-title":"RILLKKMPSV influences the vasculature, neurons and glia, and (pro)renin receptor expression in the retina","volume":"55","author":"Wilkinson-Berka","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.peptides.2012.04.008_bib0660","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1007\/s00125-011-2239-9","article-title":"Aliskiren reduces vascular pathology in diabetic retinopathy and oxygen-induced retinopathy in the transgenic (mRen-2)27 rat","volume":"54","author":"Wilkinson-Berka","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.peptides.2012.04.008_bib0665","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1161\/CIRCRESAHA.108.176008","article-title":"Identification of a retinal aldosterone system and the protective effects of mineralocorticoid receptor antagonism on retinal vascular pathology","volume":"104","author":"Wilkinson-Berka","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.peptides.2012.04.008_bib0670","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.amjhyper.2006.09.018","article-title":"Valsartan but not atenolol improves vascular pathology in diabetic Ren-2 rat retina","volume":"20","author":"Wilkinson-Berka","year":"2007","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.peptides.2012.04.008_bib0675","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1042\/CS20100389","article-title":"Angiotensin receptor blockers and angiogenesis: clinical and experimental evidence","volume":"120","author":"Willis","year":"2010","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.peptides.2012.04.008_bib0680","first-page":"125","article-title":"Pericyte biology and diseases","volume":"27","author":"Yamagishi","year":"2005","journal-title":"Int J Tissue React"},{"key":"10.1016\/j.peptides.2012.04.008_bib0685","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1016\/j.febslet.2005.06.058","article-title":"Angiotensin II augments advanced glycation end product-induced pericyte apoptosis through RAGE overexpression","volume":"579","author":"Yamagishi","year":"2005","journal-title":"FEBS Lett"},{"key":"10.1016\/j.peptides.2012.04.008_bib0690","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2337\/dc11-1909","article-title":"Global prevalence and major risk factors of diabetic retinopathy","volume":"35","author":"Yau","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.peptides.2012.04.008_bib0695","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ajo.2006.10.046","article-title":"Prorenin levels in retinopathy of prematurity","volume":"143","author":"Yokota","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.peptides.2012.04.008_bib0700","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1177\/1470320310391327","article-title":"Higher levels of prorenin predict development of diabetic retinopathy in patients with type 2 diabetes","volume":"12","author":"Yokota","year":"2011","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.peptides.2012.04.008_bib0705","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1167\/iovs.02-1193","article-title":"Captopril inhibits glucose accumulation in retinal cells in diabetes","volume":"44","author":"Zhang","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.peptides.2012.04.008_bib0710","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1080\/02713680701584123","article-title":"Captopril inhibits capillary degeneration in the early stages of diabetic retinopathy","volume":"32","author":"Zhang","year":"2007","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.peptides.2012.04.008_bib0715","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1113\/jphysiol.2010.202937","article-title":"The electrotonic architecture of the retinal microvasculature: modulation by angiotensin II","volume":"589","author":"Zhang","year":"2011","journal-title":"J Physiol"},{"key":"10.1016\/j.peptides.2012.04.008_bib0720","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1096\/fj.09-154344","article-title":"The neuroretina is a novel mineralocorticoid target: aldosterone up-regulates ion and water channels in Muller glial cells","volume":"24","author":"Zhao","year":"2010","journal-title":"FASEB J"}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978112001908?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978112001908?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T10:10:25Z","timestamp":1713867025000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978112001908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":144,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0196978112001908"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2012.04.008","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}